fr
Article scientifique
Accès libre
Anglais

A breakthrough in research on depression screening: from validation to efficacy studies

Publié dansActa Biomedica, vol. 92, no. 3, e2021215
Date de publication2021-07-01
Date de mise en ligne2021-07-01
Résumé

In the last two decades the awareness of depression as a public health issue has increased and the literature has flourished towards its primary and secondary prevention. Whereas timely targeting of depression risk factors is a frontier towards reducing the incidence of the disorder, nowadays the early diagnosis is of primary importance. Screening depressive disorders is paramount, since there are several types of depression. Besides, early diagnosis would improve the outcome of treatment, reduce the frequency of relapses and generally lead to higher levels of quality of life. We highlight the feasibility of depression screening in primary care and the need of a comprehensive public health approach.

eng
Mots-clés
  • Depression / diagnosis
  • Depression / epidemiology
  • Early Diagnosis
  • Humans
  • Mass Screening
  • Primary Health Care
  • Quality of Life
  • Depression
  • Screening
  • Primary care
  • PHQ-9
Citation (format ISO)
COSTANTINI, Luigi et al. A breakthrough in research on depression screening: from validation to efficacy studies. In: Acta Biomedica, 2021, vol. 92, n° 3, p. e2021215. doi: 10.23750/abm.v92i3.11574
Fichiers principaux (1)
Article (Published version)
Identifiants
97vues
26téléchargements

Informations techniques

Création19/02/2022 18:21:00
Première validation19/02/2022 18:21:00
Heure de mise à jour16/03/2023 07:12:43
Changement de statut16/03/2023 07:12:42
Dernière indexation01/02/2024 08:38:12
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack